DK0624569T3 - MMDA-antagonister - Google Patents

MMDA-antagonister

Info

Publication number
DK0624569T3
DK0624569T3 DK94110261T DK94110261T DK0624569T3 DK 0624569 T3 DK0624569 T3 DK 0624569T3 DK 94110261 T DK94110261 T DK 94110261T DK 94110261 T DK94110261 T DK 94110261T DK 0624569 T3 DK0624569 T3 DK 0624569T3
Authority
DK
Denmark
Prior art keywords
receptor antagonists
halo
formula
mmda
mmda receptor
Prior art date
Application number
DK94110261T
Other languages
English (en)
Inventor
Michael G Palfreyman
Francesco G Salituro
Ian A Mcdonald
Robert Schwarcz
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0624569T3 publication Critical patent/DK0624569T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK94110261T 1991-02-28 1992-02-24 MMDA-antagonister DK0624569T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66267091A 1991-02-28 1991-02-28

Publications (1)

Publication Number Publication Date
DK0624569T3 true DK0624569T3 (da) 1998-10-26

Family

ID=24658685

Family Applications (2)

Application Number Title Priority Date Filing Date
DK94110261T DK0624569T3 (da) 1991-02-28 1992-02-24 MMDA-antagonister
DK92103066.4T DK0501378T3 (da) 1991-02-28 1992-02-24 NMDA-antagonister

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92103066.4T DK0501378T3 (da) 1991-02-28 1992-02-24 NMDA-antagonister

Country Status (15)

Country Link
EP (2) EP0501378B1 (da)
JP (1) JP3168566B2 (da)
KR (2) KR100237264B1 (da)
AT (2) ATE116969T1 (da)
AU (2) AU643365B2 (da)
CA (1) CA2061836C (da)
DE (2) DE69226447T2 (da)
DK (2) DK0624569T3 (da)
ES (2) ES2069921T3 (da)
FI (1) FI920880A7 (da)
GR (1) GR3015130T3 (da)
HU (1) HU213214B (da)
IE (2) IE80774B1 (da)
NO (1) NO178727C (da)
NZ (1) NZ241718A (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115442C (en) * 1991-09-09 2003-09-23 Christopher Franklin Bigge Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
IT1265101B1 (it) * 1993-07-23 1996-10-30 Erba Carlo Spa Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
US5519055A (en) * 1993-08-06 1996-05-21 University Of Maryland At Baltimore Substituted kynurenines and process for their preparation
US5786508A (en) * 1994-07-15 1998-07-28 Pharmacia & Upjohn S.P.A. Substituted kynurenines and process for their preparation
GB9521486D0 (en) * 1995-10-20 1995-12-20 Pharmacia Spa Fluoro-substituted benzoylpropionic acid derivatives
SE9901237D0 (sv) * 1999-04-06 1999-04-06 Astra Ab Novel use
EP1964835A1 (en) * 2007-02-28 2008-09-03 Centre National de la Recherche Scientifique Derivatives of psammaplin A, a method for their synthesis and their use for the prevention or treatment of cancer
KR101308507B1 (ko) * 2011-07-07 2013-09-17 (주)비알뷰티플레볼루션 트립토판을 함유하는 여드름 치료제 및 피지분비 억제제, 및 이를 포함하는 광역학적 치료용 키트
WO2017065899A1 (en) * 2015-10-16 2017-04-20 Auspex Pharmaceuticals, Inc. Deuterated chlorokynurenines for the treatment of neuropsychiatric disorders
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions
CN112236412B (zh) * 2018-02-09 2024-01-30 维斯塔津治疗公司 4-氯代犬尿氨酸及中间体的合成

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1179866B (it) * 1984-12-12 1987-09-16 Rotta Research Lab Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono
IT1206078B (it) * 1987-06-03 1989-04-14 Polifarma Spa Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
IT1237472B (it) * 1989-10-04 1993-06-07 Polifarma Spa Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico.
DE19502075A1 (de) * 1995-01-24 1996-07-25 Grohe Armaturen Friedrich Auslaufarmatur mit Befestigungseinrichtung

Also Published As

Publication number Publication date
DK0501378T3 (da) 1995-03-20
IE65728B1 (en) 1995-11-15
DE69226447T2 (de) 1999-04-22
AU1114492A (en) 1992-09-03
ATE116969T1 (de) 1995-01-15
EP0501378A1 (en) 1992-09-02
ATE168989T1 (de) 1998-08-15
ES2122098T3 (es) 1998-12-16
NO178727B (no) 1996-02-12
HU213214B (en) 1997-03-28
FI920880L (fi) 1992-08-29
IE920631A1 (en) 1992-09-09
EP0624569B1 (en) 1998-07-29
GR3015130T3 (en) 1995-05-31
CA2061836A1 (en) 1992-08-29
CA2061836C (en) 2006-05-02
EP0501378B1 (en) 1995-01-11
FI920880A7 (fi) 1992-08-29
KR920016418A (ko) 1992-09-24
NO920784D0 (no) 1992-02-27
DE69201141T2 (de) 1995-05-11
AU643365B2 (en) 1993-11-11
JP3168566B2 (ja) 2001-05-21
DE69226447D1 (de) 1998-09-03
ES2069921T3 (es) 1995-05-16
AU656278B2 (en) 1995-01-27
NZ241718A (en) 1994-07-26
AU4497593A (en) 1993-11-18
HUT67033A (en) 1995-01-30
FI920880A0 (fi) 1992-02-27
NO178727C (no) 1996-05-22
JPH0586027A (ja) 1993-04-06
DE69201141D1 (de) 1995-02-23
IE80774B1 (en) 1999-02-10
EP0624569A1 (en) 1994-11-17
KR100261933B1 (ko) 2000-07-15
KR100237264B1 (ko) 2000-02-01
NO920784L (no) 1992-08-31
HU9200658D0 (en) 1992-05-28

Similar Documents

Publication Publication Date Title
LU90562I2 (fr) Acides imidazoalc-noiques
CY1107401T1 (el) Παραγωγα βενζοθειαζολιου πα την θεραπευτικη αντιμετωπιση της νοσου alzheimer και της νοσου parkinson
ES2135414T3 (es) Antagonistas del receptor 5-ht4.
EA200301306A1 (ru) Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
WO2003048164A3 (en) Adenosine a2a receptor antagonists
DE60103050D1 (de) Spiro[2.4]heptanaminocarbonsäure und ihre derivate
DE69226447D1 (de) NMDA Antagonisten
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
CY1119257T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα δεξτρομεθορφανης n-meθυλ-d-ασπαρτικων (nmda)
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
NO891390L (no) Fremgangsmaate for fremstilling av bicykliske aminforbindelser.
ATE201021T1 (de) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4 diazepin-6-yl)-2-methoxy-6-methylamino-3- pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung
DK0626367T3 (da) (7S)-7- (2R)-2-(3-chlorphenyl)-2-hydroxyethylamino -5,6,7,8-tetrahydronapthalen-2-yloxyeddikesyre og farmaceutisk acceptable salte deraf med beta3-adrenerg agonistvirkning, farmaceutiske præparater og laboratoriereagenser som indeholder den.
PT732332E (pt) Benzotienilpiperazinas substituidas sua utilizacao como medicamentos e processos para a sua preparacao
DK526087D0 (da) Antikonvulsive aminosyrederivater
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
ES2034484T3 (es) El uso de oxidos de tiadiazol para la preparacion de una composicion farmaceutica para el tratamiento de desordenes de motilidad gastrointestinal.
DK1142575T3 (da) Lægemidler til tör hud
RU94017664A (ru) Соединения, используемые в качестве антагонистов 5-нт-рецепторов, способ получения, фармацевтическая композиция